RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Olivier Voinnet awarded 2009 EMBO Gold Medal

Apr 22, 2009 - 4:00:00 AM
In 2004, Voinnet was selected to benefit from the highly competitive EMBO Young Investigator Programme and in 2007 he was elected an EMBO Member.

 
[RxPG] Heidelberg, Germany, 22 April 2009 - Olivier Voinnet from the CNRS Institute of Plant Molecular Biology in Strasbourg, France, is awarded the 2009 EMBO Gold Medal. The researcher receives this medal for his pioneering work on the mechanisms and roles of gene silencing via RNA in plants.

With this annual award, the European Molecular Biology Organization (EMBO) recognizes the outstanding contributions of young researchers in the molecular life sciences. The EMBO Gold Medal is widely regarded as one of the most prestigious life sciences awards in Europe, highlighting the high standards of Europe's best scientists.

Olivier Voinnet's contributions to our understanding of gene silencing via RNA have opened up new perspectives on how the activity of genes may be controlled, said Hermann Bujard, EMBO Director. His outstanding work reflects imaginative approaches and a broad understanding of biological processes.

The prizewinner conducts fundamental biological research with significant implications for medicine. RNA silencing is a newly discovered and highly competitive field in molecular biology. It describes a gene regulation process that has implications for the maintenance of genome integrity, antiviral defense, and developmental patterning in many organisms. Defects in these processes can result in major human diseases including cancer.

Olivier Voinnet is one of the most extraordinary young scientists that I have encountered, writes David Baulcombe, Professor of Botany at the Department of Plant Sciences, University of Cambridge, UK.

Already during his predoc time at Baulcombe's lab from 1996 to 2001, Voinnet's discoveries laid the foundation for his later understanding of the way plants use silencing to defend themselves against viruses, and how viruses, in turn, counteract this defense. We did not know anything about the microRNAs or small interfering RNAs at that time, says the biologist. Yet, with David, we managed to develop tools and model systems that ultimately were instrumental to ascertain the first biological role of RNA silencing, that is, antiviral defense.

Following the discovery of microRNA and short interfering RNA in a wide range of different organisms, one key question that has kept Voinnet busy over the past years is how do viruses and microbes deal with those endogenous RNA molecules? His work helped establish that pathogens commonly interfere with, or even hijack the gene silencing pathways of their hosts.

His most recent achievement was the discovery that microRNAs also control antibacterial defense by targeting genes involved in hormone responses and that, in response, bacteria produce suppressors of the miRNA pathway. Yet another illustration of the never ending molecular arms race between hosts and parasites.

Olivier Voinnet's discoveries represent true breakthroughs in his field. He has written several illuminating reviews recently, and participated as a speaker in many prestigious meetings. I consider him to be one of the most talented, original and effective young scientists, writes Witold Filipowicz from the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in his nomination letter.

Since establishing his own lab in Strasbourg in 2002, Voinnet has built up a team of 25 scientists and expanded his research to the mammalian system. We are very interested in finding out where and how the silencing by microRNAs works in human cells, says the gold medalist. We are helped in this endeavor by our parallel approaches in plant model systems, which are highly amenable to forward and reverse genetics. Another aspect he is particularly interested in at the moment is the impact of the silencing mechanism on the evolution of organisms and of their genomes, including those of viruses.

In 2004, Voinnet was selected to benefit from the highly competitive EMBO Young Investigator Programme and in 2007 he was elected an EMBO Member.

The prizewinner will receive the EMBO Gold Medal and an award of 10,000 euro on 30 August 2009 at The EMBO Meeting in Amsterdam where will give a special lecture about his research.




Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)